Smartkem's Chief Technology Officer Dr. Simon Ogier to Speak at MicroLED Connect 2025 in Eindhoven
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 23 2025
0mins
Source: Newsfilter
Smartkem Presentation at MicroLED Connect 2025: Dr. Simon Ogier, Chief Technology Officer of Smartkem, will present on September 24, 2025, discussing their innovative chip-first approach for connecting MicroLEDs to low-temperature OTFT backplanes, aimed at improving manufacturing yield and accelerating commercialization of MicroLED displays.
Smartkem's Technology and Goals: Smartkem is focused on revolutionizing electronics with its TRUFLEX® semiconductor polymers, which enable low-cost, high-performance displays across various technologies, including MicroLED, LCD, and AMOLED, while also developing a commercial-scale production process and maintaining a robust intellectual property portfolio.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy SMTK?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on SMTK
About SMTK
SmartKem, Inc. provides disruptive organic thin-film transistors, which have the potential to drive the displays. The Company’s patented TRUFLEX semiconductor and dielectric inks, or electronic polymers, are used to make transistors. Its inks enable low temperature printing processes, which are compatible with existing manufacturing infrastructure to deliver displays. Its semiconductor platform is used in various display technologies, including micro-light-emitting diode (MicroLED), LCD and AMOLED, as well as in applications in advanced computer and artificial intelligence (AI) chip packaging, sensors, and logic. The Company designs and develops its materials at its research and development facility in Manchester, the United Kingdom and provides prototyping services at the Centre for Process Innovation (CPI) in Sedgefield, the United Kingdom. The Company has an intellectual property portfolio, including 140 granted patents across 17 patent families and 40 codified trade secrets.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
SRx Health Solutions and EMJ Crypto Announce Merger Agreement
- Acquisition of Smartkem Shares: SRx Health Solutions has acquired a 4.99% stake in Smartkem, Inc. through a shelf take down, which not only strengthens the company's investment portfolio in advanced materials but also potentially lays the groundwork for future technological collaborations.
- Purchase of Convertible Preferred Securities: The company has also purchased convertible preferred securities through a non-brokered private placement, which will provide SRx Health with additional capital flexibility to support its strategic expansion and investment plans.
- Registration Statement Filed: SRx Health has filed a Form S-4 registration statement with the SEC to register common stock related to the merger transaction, ensuring transparency in the merger process and compliance with regulatory requirements, thereby enhancing investor confidence.
- Forward-Looking Statements: The company included forward-looking statements in the press release, highlighting potential risks and uncertainties associated with the merger transaction, reminding investors to carefully consider relevant information before making investment decisions.
See More
SRx Health Solutions and EMJ Crypto Enter Definitive Merger Agreement
- Merger Agreement: SRx Health Solutions has entered into a definitive merger agreement with EMJ Crypto Technologies, marking a strategic consolidation in the digital asset space that is expected to enhance their market competitiveness.
- Equity Acquisition: The company has acquired a 4.99% stake in Smartkem, Inc. through a shelf take down, which not only strengthens its investment portfolio in advanced materials but also lays the groundwork for potential future technological collaborations.
- Convertible Preferred Securities Purchase: SRx Health has also purchased convertible preferred securities through a non-brokered private placement, which will provide flexibility in its capital structure and may play a crucial role in future financing efforts.
- Registration Statement Filed: The company has filed a Registration Statement on Form S-4 with the SEC, planning to send an Information Statement and Prospectus to shareholders post-transaction, ensuring transparency and compliance with regulatory requirements.
See More
SMARTKEM INC PLANS TO ISSUE AND SELL AS MANY AS 146.8 MILLION COMMON SHARES TO KEYSTONE CAPITAL PARTNERS, ACCORDING TO SEC FILING
Company Overview: SMARTKEM, a company focused on advanced materials, is currently facing issues that have led to a significant sell-off of its common shares, dropping to 146.8 million shares.
Financial Context: The decline in share value is linked to the company's recent SEC filing, which may indicate financial challenges or operational setbacks that investors are reacting to.
See More
Veeva Systems Reports Strong Q4 Results and Raises FY27 Guidance
- Strong Financials: Veeva Systems reported Q4 revenue of $836 million, a 16% year-over-year increase, surpassing the market expectation of $810.6 million, indicating robust growth potential in the life sciences sector.
- Earnings Beat: The company posted earnings per share of $2.06, exceeding the consensus estimate of $1.93, reflecting ongoing improvements in profitability and boosting investor confidence.
- Stock Surge: Veeva Systems shares jumped 11.3% in pre-market trading to $209.81, indicating a positive market reaction to its financial performance and future outlook.
- Optimistic Guidance: The company raised its FY27 guidance above market expectations, further solidifying its leadership position in the industry and laying a strong foundation for future growth.
See More
Smartkem Unveils World's First All-Organic Transistor Biometric Sensor
- Technological Breakthrough: Smartkem's collaboration with Shanghai Jiao Tong University has resulted in the world's first all-organic transistor biometric sensor, significantly enhancing optical detection sensitivity for fingerprint and palm recognition on curved surfaces, thereby addressing challenges like fingerprint spoofing.
- Application Potential: This sensor employs advanced liveness detection techniques to capture subtle signals that distinguish real fingerprints from fakes, which not only opens new applications for flexible biometric devices but also enhances market competitiveness.
- Academic Publication: A paper detailing this innovation will be presented at the IEEE International Electron Devices Meeting on December 10, 2025, showcasing Smartkem's advancements in organic transistor technology and solidifying its leadership in the semiconductor field.
- Market Potential: Smartkem's TRUFLEX® semiconductor polymers can be utilized across various display technologies, with expectations to drive the commercialization of a new generation of lightweight, high-performance bio and optical sensors, thereby expanding its market share.
See More
Smartkem Unveils World's First All-Organic Biometric Sensor
- Technological Breakthrough: Smartkem's collaboration with Shanghai Jiao Tong University has led to the development of the world's first all-organic transistor biometric sensor, significantly enhancing optical detection sensitivity for fingerprint recognition on curved surfaces, addressing challenges like fingerprint spoofing and advancing biometric technology.
- Application Prospects: This sensor employs advanced liveness detection techniques to capture subtle signals, not only improving the differentiation between real and fake fingerprints but also potentially opening new application scenarios in flexible biometric devices, thereby enhancing market competitiveness.
- Academic Publication: A paper co-authored by Smartkem's CTO Simon Ogier will be published at the IEEE International Electron Devices Meeting on December 10, 2025, showcasing the academic value and industry impact of this technology, further elevating the company's standing in the sector.
- Market Potential: Smartkem's all-organic transistor platform not only outperforms conventional inorganic sensors in sensitivity but also paves the way for the next generation of lightweight, high-performance bio- and optical sensors, indicating broad market application potential.
See More
SRx Health Solutions and EMJ Crypto Announce Merger Agreement
- Acquisition of Smartkem Shares: SRx Health Solutions has acquired a 4.99% stake in Smartkem, Inc. through a shelf take down, which not only strengthens the company's investment portfolio in advanced materials but also potentially lays the groundwork for future technological collaborations.
- Purchase of Convertible Preferred Securities: The company has also purchased convertible preferred securities through a non-brokered private placement, which will provide SRx Health with additional capital flexibility to support its strategic expansion and investment plans.
- Registration Statement Filed: SRx Health has filed a Form S-4 registration statement with the SEC to register common stock related to the merger transaction, ensuring transparency in the merger process and compliance with regulatory requirements, thereby enhancing investor confidence.
- Forward-Looking Statements: The company included forward-looking statements in the press release, highlighting potential risks and uncertainties associated with the merger transaction, reminding investors to carefully consider relevant information before making investment decisions.
See More
SRx Health Solutions and EMJ Crypto Enter Definitive Merger Agreement
- Merger Agreement: SRx Health Solutions has entered into a definitive merger agreement with EMJ Crypto Technologies, marking a strategic consolidation in the digital asset space that is expected to enhance their market competitiveness.
- Equity Acquisition: The company has acquired a 4.99% stake in Smartkem, Inc. through a shelf take down, which not only strengthens its investment portfolio in advanced materials but also lays the groundwork for potential future technological collaborations.
- Convertible Preferred Securities Purchase: SRx Health has also purchased convertible preferred securities through a non-brokered private placement, which will provide flexibility in its capital structure and may play a crucial role in future financing efforts.
- Registration Statement Filed: The company has filed a Registration Statement on Form S-4 with the SEC, planning to send an Information Statement and Prospectus to shareholders post-transaction, ensuring transparency and compliance with regulatory requirements.
See More
SMARTKEM INC PLANS TO ISSUE AND SELL AS MANY AS 146.8 MILLION COMMON SHARES TO KEYSTONE CAPITAL PARTNERS, ACCORDING TO SEC FILING
Company Overview: SMARTKEM, a company focused on advanced materials, is currently facing issues that have led to a significant sell-off of its common shares, dropping to 146.8 million shares.
Financial Context: The decline in share value is linked to the company's recent SEC filing, which may indicate financial challenges or operational setbacks that investors are reacting to.
See More
Veeva Systems Reports Strong Q4 Results and Raises FY27 Guidance
- Strong Financials: Veeva Systems reported Q4 revenue of $836 million, a 16% year-over-year increase, surpassing the market expectation of $810.6 million, indicating robust growth potential in the life sciences sector.
- Earnings Beat: The company posted earnings per share of $2.06, exceeding the consensus estimate of $1.93, reflecting ongoing improvements in profitability and boosting investor confidence.
- Stock Surge: Veeva Systems shares jumped 11.3% in pre-market trading to $209.81, indicating a positive market reaction to its financial performance and future outlook.
- Optimistic Guidance: The company raised its FY27 guidance above market expectations, further solidifying its leadership position in the industry and laying a strong foundation for future growth.
See More
Smartkem Unveils World's First All-Organic Transistor Biometric Sensor
- Technological Breakthrough: Smartkem's collaboration with Shanghai Jiao Tong University has resulted in the world's first all-organic transistor biometric sensor, significantly enhancing optical detection sensitivity for fingerprint and palm recognition on curved surfaces, thereby addressing challenges like fingerprint spoofing.
- Application Potential: This sensor employs advanced liveness detection techniques to capture subtle signals that distinguish real fingerprints from fakes, which not only opens new applications for flexible biometric devices but also enhances market competitiveness.
- Academic Publication: A paper detailing this innovation will be presented at the IEEE International Electron Devices Meeting on December 10, 2025, showcasing Smartkem's advancements in organic transistor technology and solidifying its leadership in the semiconductor field.
- Market Potential: Smartkem's TRUFLEX® semiconductor polymers can be utilized across various display technologies, with expectations to drive the commercialization of a new generation of lightweight, high-performance bio and optical sensors, thereby expanding its market share.
See More
Smartkem Unveils World's First All-Organic Biometric Sensor
- Technological Breakthrough: Smartkem's collaboration with Shanghai Jiao Tong University has led to the development of the world's first all-organic transistor biometric sensor, significantly enhancing optical detection sensitivity for fingerprint recognition on curved surfaces, addressing challenges like fingerprint spoofing and advancing biometric technology.
- Application Prospects: This sensor employs advanced liveness detection techniques to capture subtle signals, not only improving the differentiation between real and fake fingerprints but also potentially opening new application scenarios in flexible biometric devices, thereby enhancing market competitiveness.
- Academic Publication: A paper co-authored by Smartkem's CTO Simon Ogier will be published at the IEEE International Electron Devices Meeting on December 10, 2025, showcasing the academic value and industry impact of this technology, further elevating the company's standing in the sector.
- Market Potential: Smartkem's all-organic transistor platform not only outperforms conventional inorganic sensors in sensitivity but also paves the way for the next generation of lightweight, high-performance bio- and optical sensors, indicating broad market application potential.
See More
